Nanostructured Lipid Carriers (NLCs) for Drug Delivery and Targeting
The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Nanostructured lipid carriers (NLCs) are drug-delivery systems composed of both solid and liquid lipids as a core matrix. It was shown that NLCs reveal some advantages for drug therapy over conventional carriers, including increased solubility, the ability to enhance storage stability, improved permeability and bioavailability, reduced adverse effect, prolonged half-life, and tissue-targeted delivery. NLCs have attracted increasing attention in recent years. This review describes recent developments in drug delivery using NLCs strategies. The structures, preparation techniques, and physicochemical characterization of NLCs are systematically elucidated in this review. The potential of NLCs to be used for different administration routes is highlighted. Special attention is paid to parenteral injection and topical delivery since these are the most common routes for investigating NLCs. Relevant issues for the introduction of NLCs to market, including pharmaceutical and cosmetic applications, are discussed. The related patents of NLCs for drug delivery are also reviewed. Finally, the future development and current obstacles needing to be resolved are elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Lipid vesicles and other colloids as drug carriers on the skin
Cevc, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.028 · Cited by 700
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Crystallization behaviour of fats and lipids — a review
Sato, K. (2001) · Chemical Engineering Science · doi:10.1016/s0009-2509(00)00458-9 · Cited by 625
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Silybin and Silymarin - New and Emerging Applications in Medicine
Gazak, R., Walterova, D., & Kren, V. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941159 · Cited by 573
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Self-citationLipid nanoparticles for parenteral delivery of actives
Joshi, M. D., & Müller, R. H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.003 · Cited by 433
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Nakatsuji, T., Kao, M. C., Fang, J.-Y., Zouboulis, C. C., Zhang, L., Gallo, R. L., & Huang, C.-M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.93 · Cited by 378
Self-citationPenetration of nanoparticles and nanomaterials in the skin: Fiction or reality?
Baroli, B. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21817 · Cited by 372
Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting
Chen, H., Chang, X., Du, D., Liu, W., Liu, J., Weng, T., Yang, Y., Xu, H., & Yang, X. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.052 · Cited by 323
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Docetaxel for treatment of solid tumours: a systematic review of clinical data
Montero, A., Fossella, F., Hortobagyi, G., & Valero, V. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70094-2 · Cited by 311
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Preparation and characteristics of monostearin nanostructured lipid carriers
Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., & Zeng, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.040 · Cited by 269
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
Follicular transport route – Research progress and future perspectives
Knorr, F., Lademann, J., Patzelt, A., Sterry, W., Blume-Peytavi, U., & Vogt, A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.001 · Cited by 247
Lombardi Borgia, S., Regehly, M., Sivaramakrishnan, R., Mehnert, W., Korting, H. C., Danker, K., Röder, B., Kramer, K. D., & Schäfer-Korting, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.045 · Cited by 231
Yuan, H., Wang, L.-L., Du, Y.-Z., You, J., Hu, F.-Q., & Zeng, S. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.06.011 · Cited by 215
Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib
Joshi, M., & Patravale, V. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600814676 · Cited by 213
HUANG, Z.-R., HUA, S.-C., YANG, Y.-L., & FANG, J.-Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00829.x · Cited by 200
Self-citationSaupe, A., Gordon, K. C., & Rades, T. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.022 · Cited by 199
Chattopadhyay, N., Zastre, J., Wong, H.-L., Wu, X. Y., & Bendayan, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9615-2 · Cited by 194
Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems
Sitterberg, J., Özcetin, A., Ehrhardt, C., & Bakowsky, U. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.005 · Cited by 187
Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin Effects
Souto, E. B., Almeida, A. J., & Müller, R. H. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.049 · Cited by 186
Jores, K., Mehnert, W., & Mäder, K. (2003) · Pharmaceutical Research · doi:10.1023/a:1025065418309 · Cited by 185
Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry
Castelli, F., Puglia, C., Sarpietro, M. G., Rizza, L., & Bonina, F. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.011 · Cited by 178
Tsai, M.-J., Wu, P.-C., Huang, Y.-B., Chang, J.-S., Lin, C.-L., Tsai, Y.-H., & Fang, J.-Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.009 · Cited by 177
Self-citationNeuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway
Liu, C., Wu, J., Xu, K., Cai, F., Gu, J., Ma, L., & Chen, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06561.x · Cited by 162
Recent Advances and Patents on Solid Lipid Nanoparticles
Sawant, K. K., & Dodiya, S. S. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108784534081 · Cited by 158
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 155
Tocol emulsions for drug solubilization and parenteral delivery
Constantinides, P. P., Tustian, A. K., & Kessler, D. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.005 · Cited by 153
Psoralen and Ultraviolet A Light Therapy for Psoriasis
Stern, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmct072317 · Cited by 149
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
de Souza, L. G., Silva, E. J., Martins, A. L. L., da Mota, M. F., Braga, R. C., Lima, E. M., Valadares, M. C., Taveira, S. F., & Marreto, R. N. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.012 · Cited by 146
Structural investigations on lipid nanoparticles containing high amounts of lecithin
Schubert, M. A., Harms, M., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.004 · Cited by 145
Jores, K., Haberland, A., Wartewig, S., Mäder, K., & Mehnert, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7148-5 · Cited by 142
Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.001 · Cited by 141
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., & Zhang, Q. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.06.008 · Cited by 136
Biomimetic nanoparticles: preparation, characterization and biomedical applications
Carmona‐Ribeiro, A. M. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9035 · Cited by 127
Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study
Esposito, E., Mariani, P., Ravani, L., Contado, C., Volta, M., Bido, S., Drechsler, M., Mazzoni, S., Menegatti, E., Morari, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.015 · Cited by 126
Liu, D., Liu, F., Liu, Z., Wang, L., & Zhang, N. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200402e · Cited by 108
Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice
Mu, X. L., He, G., Yuan, X., Li, X., & Du, G. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.011 · Cited by 94
Wang, J., Liu, K., Sung, K. C., Tsai, C.-Y., & Fang, J. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.008 · Cited by 90
Self-citationRosenblatt, K. M., & Bunjes, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8000759 · Cited by 83
Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., & Nie, S. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Wissing, S. A., Müller, R. H., Manthei, L., & Mayer, C. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019291.36636.c1 · Cited by 73
Development and Evaluation of Perfluorocarbon Nanobubbles for Apomorphine Delivery
Hwang, T., Lin, Y., Chi, C.-H., Huang, T., & Fang, J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21687 · Cited by 70
Self-citationApomorphine in Dopaminergic Therapy
Subramony, J. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060012c · Cited by 65
Forny, L., Saleh, K., Denoyel, R., & Pezron, I. (2009) · Langmuir · doi:10.1021/la902759s · Cited by 63
Hsu, S.-H., Wen, C.-J., Al‐Suwayeh, S. A., Chang, H., Yen, T., & Fang, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/40/405101 · Cited by 62
Self-citationEscher, M., Daali, Y., Chabert, J., Gérard Hopfgartner, D., Dayer, P., & Desmeules, J. A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.08.007 · Cited by 58
Pan, S.-Y., Yang, R., Dong, H., Yu, Z., & Ko, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.011 · Cited by 57
Investigation of Nanostructured Lipid Carriers for Transdermal Delivery of Flurbiprofen
Han, F., Li, S., Yin, R., Shi, X., & Jia, Q. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701833708 · Cited by 46
Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers
Xu, X., Zhao, C., Yang, H., Jian, Y., Zhang, Z., & Huang, Y. (2011) · Drug Delivery · doi:10.3109/10717544.2011.589087 · Cited by 29
Cited by
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Mofazzal Jahromi, M. A., Sahandi Zangabad, P., Moosavi Basri, S. M., Sahandi Zangabad, K., Ghamarypour, A., Aref, A. R., Karimi, M., & Hamblin, M. R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.001 · Cited by 551
Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Viegas, C., Patrício, A. B., Prata, J. M., Nadhman, A., Chintamaneni, P. K., & Fonte, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061593 · Cited by 524
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
Chauhan, I., Yasir, M., Verma, M., & Singh, A. P. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.021 · Cited by 518
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Salvi, V. R., & Pawar, P. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.017 · Cited by 456
Metadata
- Authors
- Fang, C.-L., A. Al-Suwayeh, S., & Fang, J.-Y.
- Venue
- Recent Patents on Nanotechnology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-01-01
- Volume
- 7
- Issue
- 1
- Pages
- 41-55
- ISSN
- 1872-2105 (ISSN-L)
- OpenAlex
- W2138361094
- Cited by
- 367
- References
- 60
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.